Hopstem Biotechnology
PrivateLast Round
Series C
Aug 10, 2026
Total Funding Raised
$55.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Hopstem Biotechnology is a biotechnology company that develops induced pluripotent stem cell (iPSC)-derived therapies for central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hopstem Biotechnology Comparables
Compare Hopstem Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XellSmart | 84% | |
| iRegene Therapeutics | 81% | |
| Allife Medicine | 80% | |
Hopstem Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 10, 2026 | ||||
| Series B | Oct 31, 2021 | ||||
| Series A Extension | May 28, 2021 | ||||
| Series A Extension | Dec 1, 2020 | ||||
| Series A | Dec 24, 2018 |
Key People
Founding team and executive leadership
Hopstem Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cybernaut Investment Group | Angel |
| Longmen Capital | Series A Extension |
| Hillhouse Investment | Series B |
| YuanBio Venture Capital | Series B, Angel, Series A Extension |
| Daoyuan Capital | Series A |
| Tasly Capital | Series C |
| Empower Investment | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 414% MoM.
- Aug 10, 2026
Raised $28M with Tasly Capital participating.
Hopstem Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hopstem Biotechnology's valuation, stock price, and market status.